36 commercial payer policies list J0896. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
36 policies from 24 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept-aamt (Reblozyl)Effective 01/01/2023 - 01/31/2024 | Jan 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Luspatercept-aamt (Reblozyl)Effective 02/01/2022 - 12/31/2022 | Feb 1, 2022 | Prior auth requiredInferred from policy title |
| Luspatercept-aamt (Reblozyl)Effective 03/01/2020 - 03/14/2021 | Mar 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Luspatercept-aamt (Reblozyl)Effective 03/15/2021 - 01/31/2022 | Mar 15, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Reblozyl (luspatercept-aamt) | Jan 1, 2026 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Reblozyl (luspatercept-aamt)Effective 02/01/2024 - 02/28/2025 | Feb 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Reblozyl (luspatercept-aamt)Effective 03/01/2025 - 12/31/2025 | Jan 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J0896 |
|---|---|---|
| Reblozyl (Luspatercept-Aamt) | Aug 1, 2026 | Covered |
| Reblozyl (Luspatercept-Aamt) – Commercial and Individual Exchange Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Reblozyl (Luspatercept-Aamt) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept–aamt (Reblozyl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Luspatercept–aamt (Reblozyl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Reblozyl (luspatercept-aamt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| State and School Employees' Health Insurance Plan - Reblozyl (luspatercept-aamt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept–aamt (Reblozyl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Luspatercept–aamt (Reblozyl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Reblozyl (luspatercept-aamt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Reblozyl (luspatercept-aamt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept-aamt (e.g., Reblozyl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J0896 |
|---|---|---|
| LUSPATERCEPT-AAMT (REBLOZYL) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| REBLOZYL (LUSPATERCEPT-AAMT) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept Reblozyl | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept-aamt (Reblozyl) | Jan 30, 2020 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept-aamt (Reblozyl); CP.PHAR.450 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Q3 - 2026 Jefferson Health Plans MedOnc Master Drug List | Not recorded | Prior auth required |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Oncology - luspatercept-aamt (Reblozyl) and imetelstat (Rytelo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Luspatercept-aamt (Reblozyl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| 00703 luspatercept-aamt (Reblozyl) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Reblozyl (luspatercept-aamt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Reblozyl (Luspatercept-Aamt) | Aug 1, 2026 | Covered |
| Policy | Effective | Status of J0896 |
|---|---|---|
| Reblozyl (Luspatercept-Aamt) | Aug 1, 2026 | Covered |